| Combination of | |
|---|---|
| Fexofenadine | Antihistamine |
| Pseudoephedrine | Nasal decongestant |
| Clinical data | |
| Trade names | Allegra-D |
| MedlinePlus | a601053 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies and the common cold. It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant.
In 2023, it was the 307th most commonly prescribed medication in the United States, with more than 300,000 prescriptions.